EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Application of Pyrrolidine in FDA‐Approved Drugs

Jiao Wang, Xiaolin Tan, Xiaoyan Wang, Yatao Wang, Hui Li, Zhong Yu, Qifang Liu iD

Medicinal Research Reviews · 18.08.2026

DOI: 10.1002/med.70100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 18.08.2026. Verfasst von Jiao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Die Arbeit nennt 157 Literaturangaben. Gefördert von: Liaoning Province Science and Technology Plan Joint Program, General Program of Liaoning Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The saturated five‐membered pyrrolidine ring is a privileged scaffold in medicinal chemistry. There is great interest in the pyrrolidine skeleton due to several key characteristics of this heterocyclic ring: its sp 3 hybridized carbon framework, the contribution of multiple chiral centers, and the inherent planarization of the ring, typically manifested as conformational flexibility or pseudorotation. These characteristics make pyrrolidine‐based structures highly attractive in the drug design for various biological targets. The pyrrolidine moiety also enhances drug‐like properties such as metabolic stability, water solubility, and modulation of basicity, and can interact favorably with a wide range of biological targets through specific stereochemical interactions. This review surveys the synthesis and clinical applications of FDA‐approved pyrrolidine‐containing drugs since 2014, with the aim of informing the rational design of next‐generation pyrrolidine‐based therapeutics.

Schlagwörter

Stichwörter der Autor:innen

FDA approvalclinical applicationpyrrolidinesynthesis

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  • Rega Institute of Medical Research, KU Leuven, Leuven, Belgium.
  • Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.

ORCID-Profile: Qifang Liu

Förderung

  • Liaoning Province Science and Technology Plan Joint Program
  • General Program of Liaoning Provincial Natural Science Foundation

Zitieren

APA

Wang, J., Tan, X., Wang, X., Wang, Y., Li, H., Yu, Z., & Liu, Q. (2026). Application of Pyrrolidine in FDA‐Approved Drugs. Medicinal Research Reviews. https://doi.org/10.1002/med.70100

Vancouver

Wang J, Tan X, Wang X, Wang Y, Li H, Yu Z, et al. Application of Pyrrolidine in FDA‐Approved Drugs. Medicinal Research Reviews. 2026. doi:10.1002/med.70100

BibTeX
@article{Wang2026,
  author = {Wang, Jiao and Tan, Xiaolin and Wang, Xiaoyan and Wang, Yatao and Li, Hui and Yu, Zhong and Liu, Qifang},
  title = {Application of Pyrrolidine in FDA‐Approved Drugs},
  journal = {Medicinal Research Reviews},
  year = {2026},
  doi = {10.1002/med.70100}
}
Kostenlos starten →